Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hyperparathyroidism, Secondary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02549404
What this trial is testing

Phase 3 Study of KHK7580

Who this might be right for
Secondary Hyperparathyroidism
Kyowa Kirin Co., Ltd. 137
Large-scale testing (Phase 3)Study completedNCT00042653
What this trial is testing

An Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis

Who this might be right for
Secondary HyperparathyroidismEnd Stage Renal Disease
Amgen 380
Not applicableStudy completedNCT07212972
What this trial is testing

Mineral Bone Disorder in Dialysis

Who this might be right for
Chronic Kidney FailureChronic Kidney Disease-Mineral and Bone DisorderDialysis+1 more
Çanakkale Onsekiz Mart University 167
Not applicableUnknownNCT05350098
What this trial is testing

Efficacy of Plant-protein Diets in Patients With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease Stage 5
Osaka University 40
Not applicableStudy completedNCT04013139
What this trial is testing

Relationship Between Cardiopulmonary Exercise Testing and Ca-P in Chronic Kidney Disease (CKD)

Who this might be right for
Ckd-Mbd
Shahid Beheshti University of Medical Sciences 200
Testing effectiveness (Phase 2)Study completedNCT01414114
What this trial is testing

Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone Disorder

Who this might be right for
Secondary Hyperparathyroidism
KAI Pharmaceuticals 37
Testing effectiveness (Phase 2)Study completedNCT00742716
What this trial is testing

Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseSecondary HyperparathyroidismChronic Renal Insufficiency+1 more
OPKO IP Holdings II, Inc. 41
Large-scale testing (Phase 3)Looking for participantsNCT03969329
What this trial is testing

Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis

Who this might be right for
Secondary Hyperparathyroidism
Amgen 24
Post-approval studies (Phase 4)Active Not RecruitingNCT05096195
What this trial is testing

PRevEnting FracturEs in REnal Disease - 1

Who this might be right for
Kidney DiseasesDialysis; ComplicationsFragility Fracture+1 more
Western University, Canada 60
Post-approval studies (Phase 4)Study completedNCT00431496
What this trial is testing

Cinacalcet to Improve Achievement of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With End Stage Renal Disease (ESRD)

Who this might be right for
AnemiaSecondary Hyperparathyroidism
Amgen 71
Testing effectiveness (Phase 2)Ended earlyNCT01576146
What this trial is testing

Open-label Study to Assess the Long-term Safety and Efficacy of Etelcalcetide (Also Known as AMG 416 or KAI-4169) in Patients With Secondary Hyperparathyroidism

Who this might be right for
Secondary Hyperparathyroidism
KAI Pharmaceuticals 30
Testing effectiveness (Phase 2)Study completedNCT06236295
What this trial is testing

Investigating the Safety and Efficacy of SHR6508 Injection in the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients : A Multicenter, Long-term Clinical Trial

Who this might be right for
Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis
Shanghai Hengrui Pharmaceutical Co., Ltd. 303
Post-approval studies (Phase 4)Ended earlyNCT00664430
What this trial is testing

Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects

Who this might be right for
Secondary HyperparathyroidismDialysis
Abbott 13
Large-scale testing (Phase 3)Study completedNCT00117052
What this trial is testing

SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary Hyperparathyroidism

Who this might be right for
Secondary HyperparathyroidismEnd Stage Renal Disease
Amgen 673
Not applicableStudy completedNCT07133256
What this trial is testing

Effects of Aerobic Versus Resistance Training on Bone Metabolism in Stage 3-4 Chronic Kidney Disease

Who this might be right for
OsteopeniaBone Metabolism DisordersChronic Kidney Disease (Stage 3-4)+1 more
Sinai University 60
Not applicableStudy completedNCT00999037
What this trial is testing

FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney Disease

Who this might be right for
Secondary Hyperparathyroidism
University of California, Los Angeles 18
Post-approval studies (Phase 4)Study completedNCT01939977
What this trial is testing

Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation.

Who this might be right for
Secondary Hyperparathyroidism Due to Renal Causes
Fundación Senefro 148
Not applicableStudy completedNCT02523209
What this trial is testing

Analysis of Bone Microarchitecture With HR-pQCT of Patients With Chronic Kidney Disease (CKD) Candidates for Renal Transplantation

Who this might be right for
Chronic Kidney DiseasesHyperparathyroidism, Secondary
Centre Hospitalier Universitaire de Saint Etienne 102
Post-approval studies (Phase 4)Study completedNCT01115543
What this trial is testing

Efficacy and Safety of Alfacalcidol Compared to Calcitriol for Treatment of Secondary Hyperparathyroidism

Who this might be right for
Secondary HyperparathyroidismEnd Stage Renal Disease
Mahidol University 32
Large-scale testing (Phase 3)Study completedNCT01219855
What this trial is testing

Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT)

Who this might be right for
Chronic Kidney DiseaseSecondary HyperparathyroidismVitamin D Insufficiency
OPKO Health, Inc. 78
Next Page